Castleark Management LLC Horizon Therapeutics Public LTD CO Transaction History

Castleark Management LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 16, 2022	SELL	$79.4 - $116.36 $1.13 Million - $1.66 Million	-14,265 Reduced 46.38%	16,495 $1.32 Million
Q1 2022 May 16, 2022	SELL	$86.42 - $109.81 $227,284 - $288,800	-2,630 Reduced 7.88%	30,760 $3.24 Million
Q4 2021 Feb 16, 2022	SELL	$98.56 - $119.91 $171,494 - $208,643	-1,740 Reduced 4.95%	33,390 $3.6 Million
Q3 2021 Nov 12, 2021	SELL	$91.91 - $110.37 $485,284 - $582,753	-5,280 Reduced 13.07%	35,130 $3.85 Million
Q2 2021 Aug 17, 2021	BUY	$86.24 - $95.92 $9,055 - $10,071	105 Added 0.26%	40,410 $3.78 Million
Q1 2021 May 14, 2021	SELL	$71.83 - $95.48 $132,167 - $175,683	-1,840 Reduced 4.37%	40,305 $3.71 Million
Q4 2020 Feb 17, 2021	SELL	$67.0 - $84.39 $14.4 Million - $18.1 Million	-214,440 Reduced 83.57%	42,145 $3.08 Million
Q3 2020 Nov 16, 2020	SELL	$55.23 - $79.93 $5.08 Million - $7.35 Million	-92,000 Reduced 26.39%	256,585 $19.9 Million
Q2 2020 Aug 14, 2020	BUY	$30.2 - $56.98 $997,506 - $1.88 Million	33,030 Added 10.47%	348,585 $19.4 Million
Q1 2020 May 13, 2020	BUY	$24.87 - $38.56 $7.85 Million - $12.2 Million	315,555 New	315,555 $9.35 Million

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Castleark Management LLC, based on Form 13F filings with the SEC.

Stay updated on Castleark Management LLC with notifications on news.